Biopharmaceutical Stocks List

Biopharmaceutical Stocks Recent News

Date Stock Title
Jul 2 CHRS Coherus out licenses Canadian rights to cancer drug Loqtorzi
Jul 2 BMY Eisai and Bristol Myers Squibb terminate ADC development deal
Jul 1 BMY Eisai receives rights to antibody drug conjugate after Bristol ends collaboration
Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
Jul 1 IVVD Invivyd announces its addition to Russell 2000 and Russell 3000 Indexes
Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
Jul 1 QURE uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52%
Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
Jul 1 BMY Eisai and Bristol Myers cancel cancer ADC deal
Jul 1 QURE Genezen to buy uniQure's gene therapy operations in Lexington
Jul 1 QURE uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
Jul 1 QURE Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Jul 1 IVVD Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
Jul 1 QURE UniQure, with sale of plant, outsources Hemgenix manufacturing
Jun 28 BMY Bristol-Myers Squibb: Time To Double Down
Jun 28 CHRS PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
Jun 27 CHRS Coherus to divest biosimilar against AbbVie’s Humira for $40M
Jun 27 BMY Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
Jun 27 BMY You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
Jun 27 IVVD Invivyd, Inc. (NASDAQ:IVVD) Is Expected To Breakeven In The Near Future
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags